| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c37e8c6eb013c1cd469063c0c908b45f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2013-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba10301d153cbf859bbf197aed72caf3 |
| publicationDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014329753-A1 |
| titleOfInvention |
Angiogenic active lytic peptides |
| abstract |
This invention relates to novel synthetic lytic peptide fragments of full-length peptides with the capacity to modulate angiogenic activity in mammals. The invention also relates to the use of such peptides in pharmaceutical compositions and in methods for treating diseases or disorders that are associated with angiogenic activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149886-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10413584-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10548944-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266712-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147854-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492499-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023111695-A1 |
| priorityDate |
2013-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |